Effects of oral administration of type I interferon on adjuvant arthritis in rats

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 19, Issue 2, 1996, Pages 133-138

  Yoshino, Shin ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Adjuvant arthritis; Delayed type hypersensitivity; Mycobacterium tuberculosis; Proliferative response; Rheumatoid arthritis; Type I interferon

Indexed keywords

INTERFERON;

ADJUVANT DISEASE; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNIZATION; LYMPH NODE CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

ANIMALIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0029994647     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/0147-9571(95)00026-7     Document Type: Article

References (20)

1. Pearson C. M. and Wood F. D. Studies of arthritis and other lesions induced in rats by the injection of Mycobacterial adjuvant. VII. Pathologic details of the arthritis and spondylitis. Am. J. Path. 42, 73-95 (1963).
2. Pearson C. M. Development of arthritis, periarthritis and periotitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91, 95-101 (1956).
3. Pearson C. M. and Wood F. D. Passive transfer of adjuvant arthritis by lymph node or spleen cells. Am. J. Path. 120, 547-560 (1964).
4. van Eden W., Holoshitz J., Nevo Z., Frenkel A., Klajman A. and Cohen I. R. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl Acad. Sci. U.S.A. 82, 5117-5120 (1985).
5. van Vollenhoven R. F., Soriano A., McCarthy P. E., Schwartz R. L., Garbrecht F. C., Thorbecke J. and Siskind G. W. The role of immunity to cartilage proteoglycan in adjuvant arthritis. Intravenous injection of bovine proteoglycan enhances adjuvant arthritis. J. Immun. 141, 1168-1173 (1988).
6. Higgins P. L. and Weiner H. L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immun. 140, 440-445 (1988).
7. Bitar D. M. and Whitacre C. C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immun. 112, 364-370 (1988).
8. Thompson H. S. G. and Staines N. A. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. J. Clin. Invest. 62, 581-586 (1985).
9. Nagler-Anderson C., Bober L. A., Robinson M. E., Siskind G. W. and Thorbecke G. J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl Acad. Sci. U.S.A. 83, 7443-7446 (1986).
10. Mattingly J. A. Immunological suppression after oral administration of antigen: III. Activation of suppressor inducer cells in the Peyer's patch. Cell. Immun. 86, 46-52 (1984).
11. Nagura H., Ohtani H., Masuda T., Kimura M. and Nakamura S. HLA-DR expression on M cells overlying Payer's patches is a common feature of human small intestine. Acta Path. Jap. 41, 818-823 (1991).
12. Wolf J. L. and Bye W. A. The membranous epithelial (M) cell and the mucosal immune system. A. Rev. Med. 35, 95-112 (1984).
13. Husby S., Jensenius J. C. and Svehag S.-E. Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand. J. Immun. 24, 447-451 (1986).
14. Bruce M. G. and Ferguson A. The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice. Immunology 59, 295-300 (1986).
15. Derbyshire J. B. Suppression of lymphocyte blastogenesis by porcine interferon-alpha. Res. Vet. Sci. 50, 376-378 (1991).
16. Burns D. K., Scott M., Phillips J. T. and Brod S. A. Oral administration of type I interferons prevents sensitization to MBP in acute EAE. J. Immun. 150, 195A (1993).
17. Wood F. D., Pearson C. M. and Tanaka A. Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats. Int. Arch. Allergy Appl. Immun. 35, 456-467 (1969).
18. Noronha A., Toscas A. and Jensen M. A. Interferon beta augments suppressor cell function in multiple sclerosis. Ann. Neurol. 27, 207-210 (1990).
19. Panitch H. S. Systemic alpha-interferon in multiple sclerosis: Long term patient follow-up. Arch. Neurol. 44, 61-63 (1987).
20. Kastrukoff L. F., Oger J. J., Hashimoto S. A., Sacks S. L., Li D. K., Palmer M. R., Koopmans R. A., Petkau A. J., Berkowit J. and Paty D. W. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. I. Clinical and MRI evaluation. Neurology 40, 479-486 (1990).